Association of virological breakthrough and clinical outcomes in entecavir-treated HBeAg-positive chronic hepatitis B

BACKGROUND & AIMS: To evaluate virological breakthrough (VBT) and the risk of hepatocellular carcinoma (HCC) in HBeAg-positive chronic hepatitis B (CHB) patients receiving entecavir (ETV) treatment. METHODS: A retrospective cohort study was conducted in a tertiary referral hospital and a total o...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yi-Jie, Yang, Sheng-Shun, Yeh, Hong-Zen, Chang, Chi-Sen, Peng, Yen-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716625/
https://www.ncbi.nlm.nih.gov/pubmed/31469875
http://dx.doi.org/10.1371/journal.pone.0221958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716625/
https://www.ncbi.nlm.nih.gov/pubmed/31469875
http://dx.doi.org/10.1371/journal.pone.0221958

Ejemplares similares